[1]
L. Pagano, “Risk of infection in elderly patients with AML and MDS treated with hypomethylating agents”, Acta Biomed, vol. 89, no. 11-S, pp. 5–39, Dec. 2018, doi: 10.23750/abm.v89i11-S.7988.